Our business is split into three core areas. Generic Drug Substances (GDS) is still the heartland for many of our customers. Custom Manufacturing Solutions (CMS) is now nearly as large and is the fastest growing part of our business. Peptides is an expression of our expertise in a certain aspect of chemistry.
Neuland is at the forefront of facilitating and accelerating drug development and cGMP manufacturing of APIs. The Company’s technical and scientific teams provide reliable solutions and services to the global pharmaceutical industry.
Neuland follows a strong set of ethical values, termed ‘The Neuland Way’, that spurs integrity and motivation among the work force. The Neuland Way is made up of five defined values: Customer Centricity; Reliability; Accountability; Ownership; Openness & Transparency; and the core of Neuland’s business is built upon these values.
Neuland launches a new e-book. The collection of articles in this e-book discusses some of the key factors driving the pharmaceutical API industry.
Neuland is attending DCAT Week 2022. Meet us at Suite-No. 401 & 402, Intercontinental Barclay, New York.
To know more about the event and to get in touch with our team of experts, Click here.
Selecting Regulatory Starting Materials: A Q&A With Neuland’s Senior VP of Supply Chain Management
Posted on April 29, 2022 by Saharsh Davuluri
As a follow-up to our recent two-part series on Regulatory Starting Materials Sourcing & Supplier Management, we sat down with Senior Vice President of Supply Chain Management at Neuland Labs…
Neuland is committed to its stakeholders for their sustainable and long-term enrichment. Investor Relations is a top priority and we aim to meet all expectations with timely and reliable information.
Neuland facilitates accelerated career growth for self-driven and motivated professionals who are willing to learn, explore and flourish with the company. If you would like to make a career with us in R&D, manufacturing, engineering, sales and marketing, finance, or supply chain management then we’d like to hear from you.